Proteus Biomedical nabs CE Mark for ingestible sensor

August 13, 2010 by MassDevice staff

Proteus Biomedical Inc. wins CE Mark approval to market its ingestible sensor and personal physiologic monitor system in the European Union.

Proteus Biomedical logo

European Union doctors may now begin prescribing Proteus Biomedical Inc.'s "Raisins."

The Redwood City, Calif.-based company won CE Mark approval for its ingestible "Raisin" sensor and personal physiologic monitor system.

Proteus also announced ISO 13485:2003 certification for the system, according to a press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp